Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Direct Comparison of the Enzymatic Characteristics and Superoxide Production of the Four Aldehyde Oxidase Enzymes Present in Mouse

Gökhan Kücükgöze, Mineko Terao, Enrico Garattini and Silke Leimkühler
Drug Metabolism and Disposition August 2017, 45 (8) 947-955; DOI: https://doi.org/10.1124/dmd.117.075937
Gökhan Kücükgöze
Institut für Biochemie and Biologie, Universität Potsdam, Potsdam, Germany (G.K., S.L.); Laboratory of Molecular Biology, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (M.T., E.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mineko Terao
Institut für Biochemie and Biologie, Universität Potsdam, Potsdam, Germany (G.K., S.L.); Laboratory of Molecular Biology, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (M.T., E.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrico Garattini
Institut für Biochemie and Biologie, Universität Potsdam, Potsdam, Germany (G.K., S.L.); Laboratory of Molecular Biology, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (M.T., E.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silke Leimkühler
Institut für Biochemie and Biologie, Universität Potsdam, Potsdam, Germany (G.K., S.L.); Laboratory of Molecular Biology, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy (M.T., E.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Schematic representation of the chromosome 1 gene cluster coding for the four mouse AOX enzymes, showing the relative length and position of the four genes encoding the indicated AOX enzymes. The four genes are transcribed in the same direction, as indicated. The numbers below each gene indicate the number of amino acids for each encoded protein.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Characterization of the mAOX1, mAOX3, mAOX4, and mAOX2 proteins expressed in E. coli. The main graphs illustrate the size-exclusion chromatograms (absorbance at 450 nm) of the indicated proteins isolated from E. coli. The UV/Vis spectra of purified (A) mAOX1, (B) mAOX3, (C) mAOX4, and (D) mAOX2 are shown in the right-most inset of each panel. These insets show the UV/Vis spectrum of air-oxidized enzymes. The UV/Vis spectra were recorded in 50 mm Tris-HCl, 200 mM NaCl, and 1 mM EDTA (pH 8.0). The 10% SDS–polyacrylamide gels of the indicated proteins after staining with Coomassie Blue are shown in the left-most inset of each panel.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Molybdenum and iron saturation of purified mAOX proteins. After purification, the molybdenum and iron content of the indicated enzymes were determined by inductively coupled plasma optical emission spectroscopy. The iron content corresponds to saturation with both, FeSI and FeSII clusters. The percentage values are calculated on the basis of the theoretical values of Moco and 2×[2Fe–2S] clusters saturation.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Activity staining of mAOX enzymes. The figure illustrates 7% native polyacrylamide gels of purified mAOX1, mAOX3, mAOX4, and mAOX2 (10 μg) run under nondenaturing conditions: Gels were stained with (A) Coomassie Brilliant Blue or 1 mM Nitro blue tetrazolium chloride following incubation with (B) 500 μM phthalazine for 5 minutes and (C) 500 μM pyridoxal-5-monophosphate overnight.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    UV/Vis spectra of mAOX enzymes reduced with NADH under anaerobic conditions. The figure illustrates UV/Vis spectra of the indicated mAOX enzymes following purification and challenge with 10 μM oxidized (solid line) and reduced with 0.5 mM NADH after 1 minute (dashed line) and 20 minute (dashed dotted line). The spectra were recorded in 50 mM Tris-HCl, 200 mM NaCl and 1 mM EDTA (pH 8.0). (A) mAOX1, (B) mAOX3, (C) mAOX4, and (D) mAOX2.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    General characterization of mAOX1, mAOX3, mAOX4, and mAOX2 after expression in E. coli TP1000 cells

    SampleSpecific ActivityaYield Ratio (280/450)Ratio (450/550)
    As PurifiedAfter Chemical Sulfuration
    nmol min−1 mg−1nmol min−1 mg−1mg/l of E. coli Culture
    mAOX1N.D.146.7 ± 19.51.2 ± 0.25.73.2
    mAOX3b104b158b0.8b5.2b3.1b
    mAOX448.4 ± 8.1585.2 ± 37.31.1 ± 0.45.43.1
    mAOX2N.D.880.4 ± 27.70.8 ± 0.25.03.2
    • N.D., no activity was detectable.

    • ↵a Specific activity was measured using 50 μM salicylaldehyde as substrate and 100 μM DCPIP as electron acceptor.

    • ↵b Data published by Mahro et al. (2011) with benzaldehyde as substrate.

    • View popup
    TABLE 2

    Steady state kinetic parameters of mAOX1, mAOX3, mAOX4, and mAOX2

    Steady-state kinetics were corrected to molybdenum saturation of 100%. Kinetic parameters were recorded in 50 mM Tris-HCl, 200 mM NaCl, and 1 mM EDTA (pH 8.0) in the presence of 100 μM DCPIP as electron acceptor. Data are mean values from three independent measurements (±S.D.).

    SubstrateKinetic ParametersmAOX1mAOX3mAOX4mAOX2
    Pyridoxalkcat (min−1)N.D.N.D.N.D.N.D.
    KM (μM)
    kcat / KM (min−1 × μM−1)
    Vanillinkcat (min−1)449.9 ± 26.4159.5 ± 3.815.9 ± 2.280.4 ± 11.5
    KM (μM)104.0 ± 17.74.6 ± 0.55.4 ± 0.52.3 ± 0.7
    kcat / KM (min–1. μM−1)4.334.52.942.1
    p-DMACkcat (min–1)116.2 ± 7.388.5 ± 4.830.5 ± 4.244.8 ± 3.7
    KM (μM)3.3 ± 0.20.5 ± 0.10.8 ± 0.10.4 ± 0.1
    kcat / KM (min–1. μM−1)34.1196.736.3125.3
    N1-Methylnicotinamidekcat (min−1)N.D.19.6 ± 4.8N.D.49.1 ± 5.7
    KM (μM)27.9 ± 2.59.4 ± 3.2
    kcat / KM (min–1. μM−1)0.75.2
    Salicylaldehydekcat (min–1)137.5 ± 2.7213.0 ± 23.4205.2 ± 6.7221.8 ± 49.7
    KM (μM)89.6 ± 2.93.5 ± 0.113.2 ± 2.421.1 ± 12.0
    kcat / KM (min–1. μM−1)1.560.415.610.5
    Retinaldehydekcat (min−1)122.7 ± 5.146.5 ± 6.810.6 ± 1.227.9 ± 0.4
    KM (μM)16.5 ± 2.432.1 ± 5.612.6 ± 2.326.4 ± 1.57
    kcat / KM (min–1. μM−1)7.41.40.81.1
    • N.D., no activity was detectable

    • View popup
    TABLE 3

    Superoxide production of mAOX1, mAOX3, mAOX4, and mAOX2

    Superoxide production of enzymes was calculated by following the reduction of 100 μM cytochrome c at 550 nm in the presence of 50 μM substrate (p-DMAC or vanillin) in 50 mM Tris-HCl, 200 mM NaCl, and 1 mM EDTA (pH 8.0) buffer. Substrate consumption was monitored directly by the decrease in UV absorbance at wavelengths of 398 and 347 nm for p-DMAC and vanillin, respectively, in the presence of oxygen as electron acceptor. Extinction coefficients used are 21,000 M–1cm−1 for cytochrome c, 30,500 M–1cm−1 for vanillin, and 25,100 M–1cm−1 for p-DMAC.

    SubstratemAOX1mAOX3mAOX4mAOX2
    VanillinSubstrate consumption (U μmol−1 of enzyme)51.8529.729.175.78
    Superoxide formation (U μmol−1 of enzyme)16.456.921.882.42
    Ratio (%)31.723.320.441.8
    p-DMACSubstrate consumption (U μmol−1 of enzyme)142.2827.4419.3715.83
    Superoxide formation (U μmol−1 of enzyme)43.475.253.846.21
    Ratio (%)30.619.119.939.3
    • One unit (U) is defined as the oxidation of 1 μmol substrate per minute under assay conditions.

Additional Files

  • Figures
  • Tables
  • Data Supplement

    • Supplemental Data -

      Supplemental Figure 1 - The chemical structures of the substrates and formed products
      used in this study

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 45 (8)
Drug Metabolism and Disposition
Vol. 45, Issue 8
1 Aug 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Direct Comparison of the Enzymatic Characteristics and Superoxide Production of the Four Aldehyde Oxidase Enzymes Present in Mouse
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Characterization of Aldehyde Oxidase Enzymes from Mouse

Gökhan Kücükgöze, Mineko Terao, Enrico Garattini and Silke Leimkühler
Drug Metabolism and Disposition August 1, 2017, 45 (8) 947-955; DOI: https://doi.org/10.1124/dmd.117.075937

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Characterization of Aldehyde Oxidase Enzymes from Mouse

Gökhan Kücükgöze, Mineko Terao, Enrico Garattini and Silke Leimkühler
Drug Metabolism and Disposition August 1, 2017, 45 (8) 947-955; DOI: https://doi.org/10.1124/dmd.117.075937
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • OATP1B Downregulation in CDCA-Treated Monkeys
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics